Table 1.
Progression to GA (Incidence) | GA Progression (Expansion) | |
---|---|---|
Shared | ARMS2/HTRA1 genotype: minor allele at rs10490924 (risk factor) | ARMS2/HTRA1 genotype: minor allele at rs10490924 (faster progression) |
Cigarette smoking (risk factor) | Cigarette smoking (faster progression) | |
Mediterranean dietary pattern (protective factor) | Mediterranean dietary pattern (slower progression) | |
Phenotypic characteristics including reticular pseudodrusen and hyperreflective foci (risk factors) | Phenotypic characteristics including reticular pseudodrusen and hyperreflective foci (faster progression) | |
Not Shared | Age (risk factor) | Age (no association) |
CFH genotype/haplotype (risk or protective factors) | CFH genotype/haplotype (no association) | |
Multiple other genetic variants, including C2/CFB and CFI (risk or protective factors) | Multiple other genetic variants, including C2/CFB and CFI (no association) | |
Genetic variants at PRMT6 and LSS (no altered risk at genome-wide significance) | Genetic variants at PRMT6 and LSS (altered progression rate) | |
Mediterranean diet food components:
|
Mediterranean diet food components:
|
|
Mediterranean diet food components:
|
Mediterranean diet food components (association with slower progression for each):
|
|
Opposite Direction | C3 genotype: minor allele at rs2230199 (risk factor) | C3 genotype: minor allele at rs2230199 (slower progression) |
APOE genotype: minor allele at rs73036519 (protective factor) | APOE genotype: minor allele at rs73036519 (faster progression) | |
Uncertain | AREDS supplements (no significant effect, with outcome as progression to GA or central GA) | AREDS supplements (nominally significant slower progression for antioxidants plus zinc vs. placebo, in post hoc analyses with low power) |
Local complement inhibition at C3 by pegcetacoplan (nominally significant decreased progression from iRORA to cRORA, in post hoc analyses of a phase II trial) | Local complement inhibition at C3 by pegcetacoplan or C5 by avacincaptad pegol (slower progression for each) |
AREDS = Age-Related Eye Disease Study; cRORA = complete retinal pigment epithelium and outer retinal atrophy; GA = geographic atrophy; iRORA = incomplete retinal pigment epithelium and outer retinal atrophy; MUFA = monounsaturated fatty acid; SFA = saturated fatty acid.